News Ipsen

Stocks

IPN

FR0010259150

Pharmaceuticals

Market Closed - Euronext Paris 16:55:00 23/10/2026 BST			5-day change	1st Jan Change
151.20 ^EUR	-0.66%		+1.48%	+27.06%

10-22	Ipsen S.A. Upgrades Financial Guidance for the Full-Year 2026	CI
10-22	Ipsen S.A., Q3 2026 Sales/ Trading Statement Call, Oct 22, 2026

All News

Mentions Relevance

10-22	Ipsen S.A. Upgrades Financial Guidance for the Full-Year 2026	CI
10-22	Ipsen S.A., Q3 2026 Sales/ Trading Statement Call, Oct 22, 2026
10-22	Ipsen raises its 2026 targets again
10-22	Ipsen delivers outstanding sales growth in the first nine months of 2026 and further upgrades its full-year guidance	GL
10-13	BlackRock falls below 5% of Ipsen's share capital
09-28	IPSEN - Buy-back programme - Art 5 of MAR - Week 39 - 2026	GL
09-25	US FDA approves Mirum's drug for rare bone disorder	RE
09-22	IPSEN - Buy-back programme - Art 5 of MAR - Week 38 - 2026	GL
09-22	Europe Is Losing the Pharma Investment Race — But the Comeback Is Within Reach: An open letter from the Chairs of AstraZeneca, Boehringer Ingelheim, Chiesi Group, Ipsen, GSK, Novo, Novartis, Roche, and Sanofi	PU
09-21	Ipsen Shares Fall After Early Launch of U.S. Generic Rival	DJ
09-21	The arrival of a generic rival to Somatuline rattles Ipsen
09-18	Ipsen Announces Board and Committee Changes	CI
09-18	Ipsen appoints Mariette Finet to its Board of Directors	GL
09-18	AlphaValue/Baader Europe Ups Price Target, Forecasts for Ipsen on 'Solid' H1 Performance	MT
09-17	Ipsen: Incorporating solid H1 operational performance + guidance upgrade
09-17	Ipsen extends its pullback despite AlphaValue
09-15	IPSEN - Buy-back programme - Art 5 of MAR - Week 36- 2026	AQ
09-14	IPSEN - Buy-back programme - Art 5 of MAR - Week 37 - 2026	GL
09-11	Health Care Flat as Traders Rotate Back Into Fuel-Sensitive Sectors - Health Care Roundup	DJ
09-07	IPSEN - Buy-back programme - Art 5 of MAR - Week 36- 2026	GL
08-31	IPSEN - Buy-back programme - Art 5 of MAR - Week 35 - 2026	GL
08-24	IPSEN - Buy-back programme - Art 5 of MAR - Week 34 - 2026	GL
08-21	Ipsen S.A. completed the acquisition of Kartos Therapeutics, Inc.	CI
08-21	Ipsen Wraps Up Purchase of US-based Kartos Therapeutics	MT
08-21	Ipsen closes the acquisition of Kartos Therapeutics